Project MIMVAC – A multilateral initiative to foster the clinical development of effective malaria vaccine candidates in…

Basic data

Acronym:
MIMVAC
Title:
A multilateral initiative to foster the clinical development of effective malaria vaccine candidates in Africa
Duration:
01/02/2020 to 31/01/2025
Abstract / short description:
MIMVAC is a large international consortium (10 partner institutions) which brings together stakeholders of the most promising and advanced malaria vaccine candidates. The overall aim of the MIMVAC project is to accelerate the development of highly effective malaria vaccines that meet the goals set by the WHO Malaria Vaccine Technology Roadmap.
Within this program, five promising malaria vaccine candidates will be tested in clinical trials in Tübingen and Africa (CHMI trials, phase 2 trials) to down-select the most promising candidate (safe, well tolerated and efficacious) for advanced clinical development beyond the project end.
Keywords:
malaria
Malaria
clinical trial
klinische Studie
Impfstoff
Plasmodium falciparum

Involved staff

Managers

Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen

Local organizational units

Department VII, Tropical Medicine
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Help

will be deleted permanently. This cannot be undone.